Search Results - "Mallat, M.J.K"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Randomized Trial of Short‐Course High‐Dose Erythropoietin in Donation After Cardiac Death Kidney Transplant Recipients by Aydin, Z., Mallat, M. J. K., Schaapherder, A. F. M., van Zonneveld, A. J., van Kooten, C., Rabelink, T. J., de Fijter, J. W.

    Published in American journal of transplantation (01-07-2012)
    “…Eryhropoiesis‐stimulating agents have demonstrated tissue‐protective effects in experimental models of ischemia‐reperfusion injury. PROTECT was a 12‐month,…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Presence of CD163+ macrophages in DCD kidneys with high DGF reduces the risk for acute cellular rejection in 6 months after kidney transplantation by van Alem, C.M.A., Bank, J.R., de Vries, D.K., Bajema, I.M., Mallat, M.J.K., de Fijter, J.W., Rotmans, J.I., van Kooten, C.

    Published in Transplant immunology (01-12-2022)
    “…Acute cellular rejection (ACR) occurs in 10% of renal allograft recipients and is characterized by leukocyte infiltration as observed in needle biopsies. ACR…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Increased Metallothionein Expression Reflects Steroid Resistance in Renal Allograft Recipients by Rekers, N. V., Bajema, I. M., Mallat, M. J. K., Anholts, J. D. H., de Vaal, Y. J. H., Zandbergen, M., Haasnoot, G. W., van Zwet, E. W., de Fijter, J. W., Claas, F. H. J., Eikmans, M.

    Published in American journal of transplantation (01-08-2013)
    “…Steroid‐refractory acute rejection is a risk factor for inferior renal allograft outcome. We aimed to gain insight into the mechanisms underlying steroid…”
    Get full text
    Journal Article
  9. 9